Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock Post author:Sam Post published:May 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Active Implants Appoints And To Board July 11, 2017 FDA Berates Lupin for Repeatedly Making Pills That Don't Meet Quality Standards November 15, 2017 Jobs Lost as Cellectar Biosciences Shutters Manufacturing Operations January 8, 2018